Logo image of DCBO

DOCEBO INC (DCBO) Stock Fundamental Analysis

NASDAQ:DCBO - Nasdaq - CA25609L1058 - Common Stock - Currency: USD

31.87  -0.12 (-0.38%)

After market: 31.87 0 (0%)

Fundamental Rating

6

DCBO gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 285 industry peers in the Software industry. Both the profitability and the financial health of DCBO get a neutral evaluation. Nothing too spectacular is happening here. DCBO is growing strongly while it is still valued neutral. This is a good combination! With these ratings, DCBO could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year DCBO was profitable.
DCBO had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: DCBO reported negative net income in multiple years.
DCBO had a positive operating cash flow in 4 of the past 5 years.
DCBO Yearly Net Income VS EBIT VS OCF VS FCFDCBO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

DCBO's Return On Assets of 14.02% is amongst the best of the industry. DCBO outperforms 89.47% of its industry peers.
DCBO has a better Return On Equity (46.29%) than 94.74% of its industry peers.
Looking at the Return On Invested Capital, with a value of 17.84%, DCBO belongs to the top of the industry, outperforming 93.68% of the companies in the same industry.
Industry RankSector Rank
ROA 14.02%
ROE 46.29%
ROIC 17.84%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
DCBO Yearly ROA, ROE, ROICDCBO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

1.3 Margins

DCBO's Profit Margin of 12.32% is fine compared to the rest of the industry. DCBO outperforms 76.49% of its industry peers.
DCBO's Operating Margin of 8.72% is fine compared to the rest of the industry. DCBO outperforms 75.79% of its industry peers.
Looking at the Gross Margin, with a value of 80.96%, DCBO belongs to the top of the industry, outperforming 84.56% of the companies in the same industry.
DCBO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.72%
PM (TTM) 12.32%
GM 80.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
DCBO Yearly Profit, Operating, Gross MarginsDCBO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

6

2. Health

2.1 Basic Checks

DCBO has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
DCBO has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for DCBO has been increased compared to 5 years ago.
The debt/assets ratio for DCBO has been reduced compared to a year ago.
DCBO Yearly Shares OutstandingDCBO Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DCBO Yearly Total Debt VS Total AssetsDCBO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 4.49 indicates that DCBO is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 4.49, DCBO is doing good in the industry, outperforming 67.37% of the companies in the same industry.
DCBO has a debt to FCF ratio of 0.05. This is a very positive value and a sign of high solvency as it would only need 0.05 years to pay back of all of its debts.
DCBO has a Debt to FCF ratio of 0.05. This is in the better half of the industry: DCBO outperforms 80.00% of its industry peers.
DCBO has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, DCBO is in the better half of the industry, outperforming 65.26% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.05
Altman-Z 4.49
ROIC/WACC1.84
WACC9.72%
DCBO Yearly LT Debt VS Equity VS FCFDCBO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 1.20 indicates that DCBO should not have too much problems paying its short term obligations.
With a Current ratio value of 1.20, DCBO is not doing good in the industry: 64.56% of the companies in the same industry are doing better.
DCBO has a Quick Ratio of 1.20. This is a normal value and indicates that DCBO is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.20, DCBO is doing worse than 64.56% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 1.2
DCBO Yearly Current Assets VS Current LiabilitesDCBO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 855.56% over the past year.
DCBO shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.96%.
DCBO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 39.25% yearly.
EPS 1Y (TTM)855.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%280%
Revenue 1Y (TTM)19.96%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%15.75%

3.2 Future

DCBO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.76% yearly.
The Revenue is expected to grow by 24.94% on average over the next years. This is a very strong growth
EPS Next Y39.51%
EPS Next 2Y29.84%
EPS Next 3Y21.71%
EPS Next 5Y27.76%
Revenue Next Year12.1%
Revenue Next 2Y13.31%
Revenue Next 3Y25.18%
Revenue Next 5Y24.94%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
DCBO Yearly Revenue VS EstimatesDCBO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
DCBO Yearly EPS VS EstimatesDCBO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 37.06, DCBO can be considered very expensive at the moment.
Based on the Price/Earnings ratio, DCBO is valued a bit cheaper than the industry average as 62.11% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of DCBO to the average of the S&P500 Index (28.79), we can say DCBO is valued slightly more expensively.
DCBO is valuated quite expensively with a Price/Forward Earnings ratio of 26.56.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DCBO indicates a somewhat cheap valuation: DCBO is cheaper than 69.12% of the companies listed in the same industry.
DCBO's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 21.38.
Industry RankSector Rank
PE 37.06
Fwd PE 26.56
DCBO Price Earnings VS Forward Price EarningsDCBO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

70.18% of the companies in the same industry are more expensive than DCBO, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, DCBO is valued a bit cheaper than the industry average as 69.47% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 34.45
EV/EBITDA 39.36
DCBO Per share dataDCBO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

DCBO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
DCBO has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as DCBO's earnings are expected to grow with 21.71% in the coming years.
PEG (NY)0.94
PEG (5Y)N/A
EPS Next 2Y29.84%
EPS Next 3Y21.71%

0

5. Dividend

5.1 Amount

No dividends for DCBO!.
Industry RankSector Rank
Dividend Yield N/A

DOCEBO INC

NASDAQ:DCBO (4/25/2025, 8:00:51 PM)

After market: 31.87 0 (0%)

31.87

-0.12 (-0.38%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-28 2025-02-28/bmo
Earnings (Next)05-09 2025-05-09
Inst Owners35.68%
Inst Owner Change-1.15%
Ins Owners1.39%
Ins Owner ChangeN/A
Market Cap964.70M
Analysts81.43
Price Target34.61 (8.6%)
Short Float %0.94%
Short Ratio1.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)32.87%
Min EPS beat(2)-25.3%
Max EPS beat(2)91.05%
EPS beat(4)3
Avg EPS beat(4)24.07%
Min EPS beat(4)-25.3%
Max EPS beat(4)91.05%
EPS beat(8)6
Avg EPS beat(8)2.32%
EPS beat(12)9
Avg EPS beat(12)124.54%
EPS beat(16)11
Avg EPS beat(16)78.48%
Revenue beat(2)1
Avg Revenue beat(2)-0.07%
Min Revenue beat(2)-0.51%
Max Revenue beat(2)0.37%
Revenue beat(4)1
Avg Revenue beat(4)-0.53%
Min Revenue beat(4)-1.42%
Max Revenue beat(4)0.37%
Revenue beat(8)1
Avg Revenue beat(8)-0.74%
Revenue beat(12)1
Avg Revenue beat(12)-1.13%
Revenue beat(16)4
Avg Revenue beat(16)-0.06%
PT rev (1m)-6.28%
PT rev (3m)-11.68%
EPS NQ rev (1m)1.2%
EPS NQ rev (3m)3.28%
EPS NY rev (1m)15.77%
EPS NY rev (3m)24.14%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)-2.18%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.89%
Valuation
Industry RankSector Rank
PE 37.06
Fwd PE 26.56
P/S 4.45
P/FCF 34.45
P/OCF 32.98
P/B 16.7
P/tB 22.84
EV/EBITDA 39.36
EPS(TTM)0.86
EY2.7%
EPS(NY)1.2
Fwd EY3.76%
FCF(TTM)0.93
FCFY2.9%
OCF(TTM)0.97
OCFY3.03%
SpS7.17
BVpS1.91
TBVpS1.4
PEG (NY)0.94
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 14.02%
ROE 46.29%
ROCE 30.44%
ROIC 17.84%
ROICexc N/A
ROICexgc N/A
OM 8.72%
PM (TTM) 12.32%
GM 80.96%
FCFM 12.91%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
F-Score7
Asset Turnover1.14
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.05
Debt/EBITDA 0.01
Cap/Depr 36.79%
Cap/Sales 0.57%
Interest Coverage 250
Cash Conversion 131.21%
Profit Quality 104.74%
Current Ratio 1.2
Quick Ratio 1.2
Altman-Z 4.49
F-Score7
WACC9.72%
ROIC/WACC1.84
Cap/Depr(3y)34.45%
Cap/Depr(5y)55.59%
Cap/Sales(3y)0.56%
Cap/Sales(5y)1.02%
Profit Quality(3y)220.57%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)855.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%280%
EPS Next Y39.51%
EPS Next 2Y29.84%
EPS Next 3Y21.71%
EPS Next 5Y27.76%
Revenue 1Y (TTM)19.96%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%15.75%
Revenue Next Year12.1%
Revenue Next 2Y13.31%
Revenue Next 3Y25.18%
Revenue Next 5Y24.94%
EBIT growth 1Y2680.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year136.07%
EBIT Next 3Y58.04%
EBIT Next 5Y42.64%
FCF growth 1Y82.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y83.22%
OCF growth 3YN/A
OCF growth 5YN/A